CDH1 and colonic neoplasm: In colon cancer cell lines, PCSK9 was shown to promote cell progression and metastasis by downregulating E-cadherin expression, inducing the colon cancer cell epithelial–mesenchymal transition process and activating PI3K/AKT signaling [30].